
To assess treatment satisfaction and zzso quality of life zzso in subjects with Type 2 diabetes treated with zzso once weekly zzso or twice daily zzso 

In this 52-week randomized, zzso zzso study, 295 subjects managed with diet and exercise and/or oral zzso medications received either zzso zzso or zzso during weeks zzso thereafter, subjects receiving zzso zzso were switched to zzso zzso with 258 total subjects receiving zzso zzso during weeks zzso Diabetes Treatment zzso zzso zzso and Impact of Weight on Quality of zzso zzso were assessed at baseline and weeks 30 and zzso Mean group changes from baseline to week 30 were estimated by zzso changes from week 30 to week 52 were assessed by zzso zzso 

zzso significant improvements from baseline to week 30 were observed in both treatment groups for zzso and zzso measures, with significantly greater reduction in perceived frequency of zzso and greater satisfaction with continuing treatment in the zzso group compared with the zzso zzso Effect sizes for change in zzso total scores were zzso zzso zzso zzso for zzso zzso zzso zzso zzso Treatment satisfaction and zzso improved significantly between weeks 30 and 52 for those switching from zzso to zzso zzso of adverse events did not affect patients' improvements in treatment satisfaction and zzso 

Patients treated with zzso zzso or zzso experienced significant and clinically meaningful improvements in treatment satisfaction and zzso Patients who switched from zzso zzso to zzso zzso administration reported further significant zzso 

